Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 310

The DOI matches its Crossref record; 77 of the 77 references it cites were found in a registry or an index.

Humoral Innate Immunity and Acute-Phase Proteins

Open access
Mantovani, Alberto, Garlanda, Cecilia·2023·New England Journal of Medicine

Abstract

he broad term "inflammation" encompasses a diverse set of tissue reactions classically triggered by microbial recognition and by tissue damage.1,2 More recently, it has been recognized that dysmetabolic conditions, ranging from diabetes to obesity, elicit overt or subclinical inflammatory reactions.The general role of inflammatory reactions is in the amplification of innate resistance and tissue repair, leading to a return to homeostasis (Fig. 1A).Systemic manifestations of inflammation include fever, alterations in leukocyte counts, cardiovascular reactions, endocrine responses, and reorientation of metabolism in association with increased production of a diverse set of molecules referred to as acute-phase proteins.4,5 The prototypic acute-phase protein, C-reactive protein, was originally described as a molecule that was present in the circulation of patients with infections and that was capable of recognizing the C-type polysaccharides of Streptococcus pneumoniae.6,7 The appearance of increased levels of acutephase proteins in blood and other body fluids (Fig. 1B) is part of a more complex response to local inflammation or to systemic inflammation (e.g., sepsis) that has been referred to as the acute-phase response, 5 which is characterized by decreased production of albumin by hepatocytes, reorientation of iron metabolism, and hormonal changes.4,5 These alterations are also observed in the context of chronic inflammatory conditions and subclinical inflammation.Almost a century after the discovery of C-reactive protein, acute-phase proteins continue to serve as fundamental diagnostic tools that have applications in patients with a range of conditions, including infection, cardiovascular illness, cancer, neurodegeneration, and dysmetabolism.[8][9][10] During the coronavirus disease 2019 (Covid-19) pandemic, acute-phase proteins such as C-reactive protein, fibrinogen and its degradation product d-dimer, and ferritin have served as invaluable tools in the day-to-day management of illnesses and as prognostic indicators (Table 1).Progress has been made in dissecting the production, structure, and function of many of these molecules, and the findings have indicated that a fundamental function of the acute-phase response is to amplify antimicrobial resistance and tissue repair, with many of the acute-phase proteins serving as key components of humoral innate immunity ("ante-antibodies"). 25 From this general perspective, we review key aspects of the production, structure, and function of selected acute-phase proteins, which continue to represent pillar diagnostic tools that could be integrated more systematically into the molecular signatures that have recently emerged from transcriptomic and proteomic profiles. The Conte x t: Cellul a r a nd Humor a l Innate Immunit yInnate immunity is a first line of resistance against microbial pathogens and is involved in the activation of adaptive immune responses, as well as in tissue repair.Innate immunity is made up of a cellular arm and a humoral arm.The molecular strategies used by the cellular arm to sense microbial moieties and tissue damage

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1056/nejmra2206346

Cites

77 of 77 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 77 references

Cited by

See all 310

Metadata

Authors
Mantovani, A., & Garlanda, C.
Venue
New England Journal of Medicine
Published
2023-02-02
Volume
388
Issue
5
Pages
439-452
ISSN
  • 0028-4793 (ISSN-L)
  • 1533-4406
OpenAlex
W4318931822
Cited by
310
References
77
FWCI
27.18
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Humoral Innate Immunity and Acute-Phase Proteins. https://app.cochat.ai/papers/10.1056/nejmra2206346
The paper
Mantovani, A., & Garlanda, C. (2023). Humoral Innate Immunity and Acute-Phase Proteins. New England Journal of Medicine. https://doi.org/10.1056/nejmra2206346

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.